Evidence map›Paper›PMID 34590515›Full record

ArticleJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2022

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards.

Deniz C Guven, Imdat Eroglu, Rashad Ismayilov, Ege Ulusoydan, Oktay H Aktepe, Gulcin Telli Dizman, Zafer Arik, Omer Dizdar, Serhat Unal, Gokhan Metan and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Deniz C GuvenDepartment of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey.ORCID 0000-0002-6924-9467
Imdat ErogluDepartment of Internal Medicine, 37515Hacettepe University, Turkey.
Rashad IsmayilovDepartment of Internal Medicine, 37515Hacettepe University, Turkey.
Ege UlusoydanDepartment of Internal Medicine, 37515Hacettepe University, Turkey.
Oktay H AktepeDepartment of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey.ORCID 0000-0003-3540-0701
Gulcin Telli DizmanDepartment of Clinical Microbiology and Infectious Disease, 37515Hacettepe University, Turkey.
Zafer ArikDepartment of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey.
Omer DizdarDepartment of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey.
Serhat UnalDepartment of Clinical Microbiology and Infectious Disease, 37515Hacettepe University, Turkey.
Gokhan MetanDepartment of Clinical Microbiology and Infectious Disease, 37515Hacettepe University, Turkey.
Neyran KertmenDepartment of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey.
Hacettepe University · TRHacettepe University Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIt was previously demonstrated that seasonal influenza incidence was significantly decreased during the COVID-19 pandemic, possibly due to respiratory and hygiene precautions. From this point, we hypothesized that the COVID-19 precautions could lead to a decrease in nosocomial infection rates in oncology inpatient wards.

methodsWe evaluated the nosocomial infection rates in an inpatient palliative oncology ward in the first 3 months of the COVID-19 pandemic in our country and compared this rate with the same time frame of the previous year in our institution.

resultsThe percentage of nosocomial infections complicating the hospitalization episodes were significantly reduced in the first 3 months of the pandemic compared to the previous year (43 vs. 55 nosocomial infection episodes; 18.6% vs. 32.2%,

conclusionThe continuation of the simple and feasible hygiene and distancing measures for healthcare workers and patient relatives and adaptations for earlier discharge could be beneficial for preventing nosocomial infections in oncology wards. These measures could be implemented routinely even after the COVID-19 pandemic for patient safety, especially in settings with higher nosocomial infection rates like inpatients palliative care units.

Indexed as

BacteremiaCOVID-19Cross InfectionHumansHygienePandemicsCancerCOVID-19inpatient wardnosocomial infectionpandemic

Identifiers

PMID34590515
PMCPMC9626366
OpenAlexW3203268404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.